1.2600
+0.0800
+(6.78%)
At close: April 17 at 4:00:01 PM EDT
1.2600
0.00
(0.00%)
After hours: April 17 at 4:05:11 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-68,373
-68,373
-78,205
-86,959
-143,830
Investing Cash Flow
149,297
149,297
-80,084
70,715
-36,609
Financing Cash Flow
960
960
150,361
1,659
122,777
End Cash Position
182,840
182,840
100,956
108,884
123,469
Income Tax Paid Supplemental Data
944
944
--
--
--
Capital Expenditure
-3,706
-3,706
-1,764
-3,623
-6,201
Issuance of Capital Stock
--
--
616
1,085
117,818
Free Cash Flow
-72,079
-72,079
-79,969
-90,582
-150,031
12/31/2021 - 10/10/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CTMX CytomX Therapeutics, Inc.
0.6560
+4.18%
KPTI Karyopharm Therapeutics Inc.
4.9500
+11.99%
KURA Kura Oncology, Inc.
5.90
+2.61%
MRSN Mersana Therapeutics, Inc.
0.3547
+5.63%
KALA KALA BIO, Inc.
3.4550
+2.52%
ZNTL Zentalis Pharmaceuticals, Inc.
1.2900
+2.38%
STRO Sutro Biopharma, Inc.
0.5246
-2.85%
ATRA Atara Biotherapeutics, Inc.
6.17
+5.65%
XNCR Xencor, Inc.
9.70
+1.89%
GLYC GlycoMimetics, Inc.
0.2230
+0.45%